Skip to main content
. 2021 Sep 6;2021(9):CD011556. doi: 10.1002/14651858.CD011556.pub2

Sippel 1999.

Study characteristics
Methods Design: Randomized controlled trial
Setting: 2 university‐affiliated primary care clinics, USA
Recruitment: Patients approached by research staff in practice
Participants 205 adults who smoked, average age 38 years, 62% F, 20 cpd
Interventions Intervention: participants received advice and cessation information. Additionally, they spent 10 ‐ 15 minutes receiving spirometry, carbon monoxide analysis, interpretation and education
Control: participants received advice and cessation information
Outcomes Continuous abstinence at 6m
Validation: None
Secondary outcomes: Quit attempts > 24 hours
Funding Source Funded by the American Lung Association of Oregon and the American Academy of Family Practice
Author's declarations of interest Not reported.
Notes Strategies: Spirometry + CO monitoring
Level: Patient
Comparison type: Multi‐component vs. standard care
Risk of bias
Bias Authors' judgement Support for judgement
Sequence Generation High risk QUOTE: "questionnaires were numbered consecutively at each clinic throughout the study period. Subjects receiving odd‐numbered questionnaires were selected as the intervention group and those receiving even‐numbered questionnaires were selected as the control group..."
Allocation concealment High risk QUOTE: "the nurses performing patient check‐in were blinded to the questionnaire numbers. As four to six nurses conducted patient check‐ins independently and simultaneously at each clinic, it is unlikely that any given patient would be preferentially enrolled into either study arm". It is unclear how the nurses were blinded to the questionnaire numbers.
Blinding of outcome assessors
All outcomes High risk Smoking status was self‐reported and face‐to‐face was different between the groups
Incomplete outcome data
All outcomes Low risk The overall loss to follow‐up was 15.6% (n = 32/205); 12.6% (n = 13/103) in the intervention group and 18.6% (n = 19/102) were lost to follow‐up at 6 months